EMEA-002588-PIP01-19

Key facts

Active substance
  • atazanavir (sulfate)
  • ritonavir
Therapeutic area
Infectious diseases
Decision number
P/0396/2019
PIP number
EMEA-002588-PIP01-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Pharmaceutical Oriented Services Ltd

E-mail: emakrodouli@pharosgr.grskoukaki@pharosgr.gr
Tel. +30 2106664667

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating